UK drug maker AstraZeneca<\/a> is looking to open a new centre of excellence<\/a> for Internet of things<\/a> at the British-Swedish drug maker’s facility in Chennai<\/a>.

IoT<\/a>, robotics<\/a> and data science capabilities, apart from augmented and virtual reality, are going to be the dominant technologies going forward for the company and its India centres will be looking at all of these technologies and will be innovating for the globe, said Cindy L Hoots, AstraZeneca’s chief digital and technology officer.

India is increasingly becoming a hub for innovation for the company, and it has more than 100 vacancies in the country which it will be looking to fill shortly, she said.

\"We're going to be doing quite a lot of work in IoT, so we're setting up a centre of excellence around IoT here (in Chennai),\" Hoots told ET. \"We've just started a centre of expertise around augmented reality and virtual reality which will be one of the dominant technologies in the next 10 years.\"

It does not have any such centres for IoT anywhere else in the world, she added.

\"We have 28 manufacturing sites worldwide where we will start to use IoT even further,\" Hoots said. \"We're in the planning stage where we are understanding what the business needs are, how big will this really be, and then we'll move a team here. So, I would imagine that we're probably looking at the end of first quarter next year before we would start to actually hire (for the
IoT centre<\/a> in Chennai).\"

The virtual reality team has been launched with about eight people, but since it is going to be a dominant and pervasive technology, there is a need to scale it up, she said.

\"What we've been doing in addition to reskilling people is also using robotic process automation to handle routine work and free up resources to now put into more innovation type roles like IoT, machine learning, AI and so on,\" Hoots said.

As a result, she said, she expected more than 100 roles to move to the centre in the next 18 months or so. This number could even touch 200 as AstraZeneca is looking to grow more roles in India for IT than anywhere else.

Hoots said the company was also looking to expand its capabilities in India in emerging technologies like AI and machine learning, data science and data engineering. She said 50% of her global team was based in Chennai.

\"As we start driving more innovation out of India, then some of those innovation roles that we currently have in other parts of the world will come here,\" she said. \"We've been gearing up to think about our building's space, whether we can accommodate more people, how do we attract talent ... We're definitely looking to hire new, bright young minds in this space.\"
<\/p><\/body>","next_sibling":[{"msid":94442484,"title":"Netflix and Disney poised to shake up TV ad world","entity_type":"ARTICLE","link":"\/news\/netflix-and-disney-poised-to-shake-up-tv-ad-world\/94442484","category_name":null,"category_name_seo":"telecomnews"}],"related_content":[{"msid":"94439267","title":"AstraZeneca China summoned over suspected fraud","entity_type":"IMAGES","seopath":"tech\/tech-bytes\/uk-drug-maker-astrazeneca-eyes-iot-centre-in-chennai\/astrazeneca-china-summoned-over-suspected-fraud","category_name":"UK drug maker AstraZeneca eyes IoT centre in Chennai","synopsis":false,"thumb":"https:\/\/etimg.etb2bimg.com\/thumb\/img-size-26494\/94439267.cms?width=150&height=112","link":"\/image\/tech\/tech-bytes\/uk-drug-maker-astrazeneca-eyes-iot-centre-in-chennai\/astrazeneca-china-summoned-over-suspected-fraud\/94439267"}],"msid":94442566,"entity_type":"ARTICLE","title":"UK drug maker AstraZeneca eyes IoT centre in Chennai","synopsis":"IoT, robotics and data science capabilities, apart from augmented and virtual reality, are going to be the dominant technologies going forward for the company and its India centres will be looking at all of these technologies and will be innovating for the globe, said Cindy L Hoots, AstraZeneca\u2019s chief digital and technology officer.","titleseo":"telecomnews\/uk-drug-maker-astrazeneca-eyes-iot-centre-in-chennai","status":"ACTIVE","authors":[{"author_name":"Dia Rekhi","author_link":"\/author\/479241730\/dia-rekhi","author_image":"https:\/\/etimg.etb2bimg.com\/authorthumb\/479241730.cms?width=100&height=100&hid=268","author_additional":{"thumbsize":false,"msid":479241730,"author_name":"Dia Rekhi","author_seo_name":"dia-rekhi","designation":"Correspondent","agency":false}}],"Alttitle":{"minfo":""},"artag":"ETtech","artdate":"2022-09-26 07:45:50","lastupd":"2022-09-26 07:46:40","breadcrumbTags":["internet of things","astrazeneca","centre of excellence","chennai","iot","robotics","astrazeneca","Industry","IoT Centre"],"secinfo":{"seolocation":"telecomnews\/uk-drug-maker-astrazeneca-eyes-iot-centre-in-chennai"}}" data-authors="[" dia rekhi"]" data-category-name="" data-category_id="" data-date="2022-09-26" data-index="article_1">

英国制药商阿斯利康在钦奈眼睛物联网中心

物联网、机器人技术和数据科学能力,除了增强和虚拟现实,要为公司前进的主导技术,其印度中心将考虑所有这些技术,将成为全球创新说辛迪L咄,阿斯利康的数字和技术总监。

Dia Rekhi
  • 更新2022年9月26日上午07:46坚持

英国制药商阿斯利康想要打开一个新的吗卓越中心物联网在British-Swedish药物制造商的设施钦奈

物联网,机器人和数据科学能力,除了增强和虚拟现实,未来将主导技术的公司及其印度中心将考虑所有这些技术,将成为全球创新,说辛迪L咄,阿斯利康的数字和技术总监。

印度正日益成为一个公司的创新中心,它拥有超过100个空缺职位的国家,它将寻求填补不久,她说。

广告
“我们将在物联网做相当多的工作,所以我们设置一个卓越中心围绕物联网在钦奈,“咄告诉等。“我们刚刚开始一个中心的专业知识增强现实和虚拟现实的主导技术之一在未来10年。”

它没有任何此类中心物联网世界上其他地方,她补充道。

“我们有全球28个生产地点,我们将开始进一步使用物联网,“咄说。“我们在计划阶段我们理解业务需求在哪里,这真的会多大,然后我们将一个团队。所以,我会想象我们可能看明年第一季度结束前我们将开始雇佣(物联网中心在钦奈)。”

虚拟现实与八人团队已经启动,但由于它是一个主要和普遍的技术,需要规模,她说。

“我们一直在做除了reskilling人也使用机器人过程自动化处理日常工作和释放资源现在投入更多的创新类型角色如物联网、机器学习、人工智能等等,“咄说。

结果,她说,她预计超过100走中间路线的角色在接下来的18个月左右。这个数字甚至可以触摸200阿斯利康正寻求在印度种植更多的角色比其他地方。

广告
咄表示,该公司也在寻求扩大其功能在印度等新兴技术的人工智能和机器学习,数据科学与数据工程。她说她的全球团队是建立在钦奈的50%。

“当我们开始更多的创新印度,然后我们目前有一些创新的角色在世界其他地方将过来,”她说。“我们已经准备考虑建筑的空间,我们是否可以容纳更多的人,我们如何吸引人才……我们肯定希望雇佣新,明亮的年轻人在这个空间”。

  • 发布于2022年9月26日07:45点坚持
是第一个发表评论。
现在评论

加入2 m +行业专业人士的社区

订阅我们的通讯最新见解与分析。乐动扑克

下载ETTelec乐动娱乐招聘om应用

  • 得到实时更新
  • 保存您最喜爱的文章
扫描下载应用程序

UK drug maker AstraZeneca<\/a> is looking to open a new centre of excellence<\/a> for Internet of things<\/a> at the British-Swedish drug maker’s facility in Chennai<\/a>.

IoT<\/a>, robotics<\/a> and data science capabilities, apart from augmented and virtual reality, are going to be the dominant technologies going forward for the company and its India centres will be looking at all of these technologies and will be innovating for the globe, said Cindy L Hoots, AstraZeneca’s chief digital and technology officer.

India is increasingly becoming a hub for innovation for the company, and it has more than 100 vacancies in the country which it will be looking to fill shortly, she said.

\"We're going to be doing quite a lot of work in IoT, so we're setting up a centre of excellence around IoT here (in Chennai),\" Hoots told ET. \"We've just started a centre of expertise around augmented reality and virtual reality which will be one of the dominant technologies in the next 10 years.\"

It does not have any such centres for IoT anywhere else in the world, she added.

\"We have 28 manufacturing sites worldwide where we will start to use IoT even further,\" Hoots said. \"We're in the planning stage where we are understanding what the business needs are, how big will this really be, and then we'll move a team here. So, I would imagine that we're probably looking at the end of first quarter next year before we would start to actually hire (for the
IoT centre<\/a> in Chennai).\"

The virtual reality team has been launched with about eight people, but since it is going to be a dominant and pervasive technology, there is a need to scale it up, she said.

\"What we've been doing in addition to reskilling people is also using robotic process automation to handle routine work and free up resources to now put into more innovation type roles like IoT, machine learning, AI and so on,\" Hoots said.

As a result, she said, she expected more than 100 roles to move to the centre in the next 18 months or so. This number could even touch 200 as AstraZeneca is looking to grow more roles in India for IT than anywhere else.

Hoots said the company was also looking to expand its capabilities in India in emerging technologies like AI and machine learning, data science and data engineering. She said 50% of her global team was based in Chennai.

\"As we start driving more innovation out of India, then some of those innovation roles that we currently have in other parts of the world will come here,\" she said. \"We've been gearing up to think about our building's space, whether we can accommodate more people, how do we attract talent ... We're definitely looking to hire new, bright young minds in this space.\"
<\/p><\/body>","next_sibling":[{"msid":94442484,"title":"Netflix and Disney poised to shake up TV ad world","entity_type":"ARTICLE","link":"\/news\/netflix-and-disney-poised-to-shake-up-tv-ad-world\/94442484","category_name":null,"category_name_seo":"telecomnews"}],"related_content":[{"msid":"94439267","title":"AstraZeneca China summoned over suspected fraud","entity_type":"IMAGES","seopath":"tech\/tech-bytes\/uk-drug-maker-astrazeneca-eyes-iot-centre-in-chennai\/astrazeneca-china-summoned-over-suspected-fraud","category_name":"UK drug maker AstraZeneca eyes IoT centre in Chennai","synopsis":false,"thumb":"https:\/\/etimg.etb2bimg.com\/thumb\/img-size-26494\/94439267.cms?width=150&height=112","link":"\/image\/tech\/tech-bytes\/uk-drug-maker-astrazeneca-eyes-iot-centre-in-chennai\/astrazeneca-china-summoned-over-suspected-fraud\/94439267"}],"msid":94442566,"entity_type":"ARTICLE","title":"UK drug maker AstraZeneca eyes IoT centre in Chennai","synopsis":"IoT, robotics and data science capabilities, apart from augmented and virtual reality, are going to be the dominant technologies going forward for the company and its India centres will be looking at all of these technologies and will be innovating for the globe, said Cindy L Hoots, AstraZeneca\u2019s chief digital and technology officer.","titleseo":"telecomnews\/uk-drug-maker-astrazeneca-eyes-iot-centre-in-chennai","status":"ACTIVE","authors":[{"author_name":"Dia Rekhi","author_link":"\/author\/479241730\/dia-rekhi","author_image":"https:\/\/etimg.etb2bimg.com\/authorthumb\/479241730.cms?width=100&height=100&hid=268","author_additional":{"thumbsize":false,"msid":479241730,"author_name":"Dia Rekhi","author_seo_name":"dia-rekhi","designation":"Correspondent","agency":false}}],"Alttitle":{"minfo":""},"artag":"ETtech","artdate":"2022-09-26 07:45:50","lastupd":"2022-09-26 07:46:40","breadcrumbTags":["internet of things","astrazeneca","centre of excellence","chennai","iot","robotics","astrazeneca","Industry","IoT Centre"],"secinfo":{"seolocation":"telecomnews\/uk-drug-maker-astrazeneca-eyes-iot-centre-in-chennai"}}" data-news_link="//www.iser-br.com/news/uk-drug-maker-astrazeneca-eyes-iot-centre-in-chennai/94442566">